Zobrazeno 1 - 10
of 19
pro vyhledávání: '"D. V. Gogolin"'
Publikováno v:
Сибирский онкологический журнал, Vol 23, Iss 1, Pp 142-154 (2024)
Background. Glioblastoma (GB) remains an aggressive disease with a poor prognosis. despite a comprehensive approach to the treatment of the primary disease, recurrence is almost inevitable. There is still no standard of care for GB recurrence, and ma
Externí odkaz:
https://doaj.org/article/4794bc6025074cf5b0c26d81a066d379
Publikováno v:
Опухоли головы и шеи, Vol 12, Iss 4, Pp 39-47 (2023)
Introduction. Recurrence of head and neck tumors occurs in 50 % of cases and usually has locoregional character. Due to the characteristics of dose distribution, proton beam therapy is a promising treatment option for patients with recurrences of tum
Externí odkaz:
https://doaj.org/article/476a57aed84c4fa898ceaf6f7373b7a4
Autor:
T. A. Kireeva, Yu. V. Gumenetskaya, D. V. Gogolin, K. B. Gordon, I. A. Gulidov, O. G. Lepilina
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 1, Pp 144-150 (2022)
Background. Despite the fact that cerebral astrocytoma belongs to low-grade tumors (grade II gliomas), it often leads to disability and death of patients. The localization of the tumor determines the severity of the clinical symptoms of the disease,
Externí odkaz:
https://doaj.org/article/5ecd25501aad463eb8af02a775230e9a
Autor:
D. V. Gogolin, I. A. Gulidov, K. E. Medvedeva, Y. A. Ragulin, Y. S. Mardinsky, I. N. Ivanova, L. V. Kursova, I. I. Kotuhov, A. Y. Buksha
Publikováno v:
Сибирский онкологический журнал, Vol 18, Iss 4, Pp 21-26 (2019)
The purpose of the study was to compare the efficacy and toxicity of hypofractionated versus hyperfractionated radiotherapy in patients with inoperable lung cancer.Material and Methods. Patients with inoperable lung cancer, who were treated between 2
Externí odkaz:
https://doaj.org/article/5472422c4e4b4d40ba11d27bce50f8b6
Autor:
I. A. Gulidov, K. B. Gordon, D. V. Gogolin, Yu. S. Mardynsky, O. G. Lepilina, D. V. Neledov, V. N. Galkin, A. D. Kaprin
Publikováno v:
Сибирский онкологический журнал, Vol 16, Iss 5, Pp 63-70 (2017)
Recently, there has been a growing interest in the use of active beam scanning proton therapy for re-irradiation of CNS tumors. Although this treatment option for recurrent intracranial tumors is considered effective, however, it is rarely used becau
Externí odkaz:
https://doaj.org/article/85a5845e37194c2fbcf2239b8ef8eb44
Autor:
I. A. Gulidov, I. N. Ivanova, D. V. Gogolin, A. I. Gorsky, L. V. Kursova, A. Ju. Bouksha, Yu. A. Ragulin
Publikováno v:
Сибирский онкологический журнал, Vol 1, Iss 5, Pp 14-20 (2016)
Background and purpose. The purpose of this investigation was to evaluate feasibility, safety and efficacy of radiotherapy for inoperable non-small-cell lung cancer (NSCLC). Various radiotherapy planning methods have been proposed to decrease normal
Externí odkaz:
https://doaj.org/article/4da22a14ba14406493fa5d2c7abc1814
Autor:
I. A. Gulidov, A. G. Zolotkov, Yu. S. Mardynsky, I. N. Ivanova, L. V. Kursova, D. V. Gogolin, Yu. A. Ragulin
Publikováno v:
Сибирский онкологический журнал, Vol 0, Iss 1, Pp 12-15 (2016)
The 5-year treatment outcomes of 69 patients with stage IIA–IIIA locally advanced small cell lung cancer have been presented. Accelerated hyperfractionated radiotherapy was administered in the uneven daily dose fractionation (single dose of 1 + 1,5
Externí odkaz:
https://doaj.org/article/5dc8559b8d90490183c6949f961ec475
Autor:
D. V. Gogolin, I. A. Gulidov, Ju. S. Mardynskij, I. N. Ivanova, Ju. A. Ragulin, L. V. Kursova
Publikováno v:
Сибирский онкологический журнал, Vol 0, Iss 6, Pp 5-9 (2016)
This study presents the results of chemoradiation treatment with accelerated hyperfractionated regime with uneven crushing daily dose in patients with unresectable non-small cell lung cancer. The study included 187 patients with confirmed diagnosis o
Externí odkaz:
https://doaj.org/article/bbdf3cba647d4b269840cbc9869bf73a
Autor:
I A, Gulidov, Yu S, Mardynsky, V E, Balakin, V N, Galkin, D V, Gogolin, Kb Gordon, A D, Kaprin, O G, Lepilina, S E, Ulyanenko, E V, Khmelevsky
Publikováno v:
Voprosy onkologii. 62(5)
On November 23, 2015 in Protvino of the Moscow Region there was begun proton therapy using Russia's first medical therapeutic complex "Prometheus" produced by JSC "PRO- TOM" and certified to treat patients with head and neck tumors. The complex allow
Publikováno v:
Journal of Thoracic Oncology. 12:S2016